Genetically Engineered Babies: What Is Real, What Is Not, and Why It Matters

 

 

When I started looking into genetically engineered babies, I wanted to separate what is scientifically real from what is being exaggerated. The answer is more complicated than either science fiction or marketing would have us believe.

Genetic testing of embryos already happens in some IVF settings. Genome-editing tools such as CRISPR are real and are transforming biomedical research. However, creating a child from a genetically edited embryo is not an established medical service. It is not a routine form of fertility care, and the scientific, ethical, and governance barriers remain enormous.

The most important distinction is simple: testing an embryo is not the same as selecting an embryo, and selecting an embryo is not the same as editing an embryo’s DNA.

Quick Summary

  • “Genetically engineered babies” usually refers to heritable genome editing: changing DNA in an embryo in a way that could be passed to future generations.
  • Heritable human genome editing is not an established or accepted clinical practice.
  • Preimplantation genetic testing can examine embryos created through IVF. It does not edit their DNA.
  • Polygenic embryo screening attempts to estimate probabilities for complex conditions, but major fertility experts say it is not ready for clinical use.
  • Claims about selecting intelligence, athleticism, personality, or a guaranteed healthy child greatly exceed current science.
  • The central issues are safety, informed consent, disability rights, equity, commercial pressure, and who gets to decide which traits are “desirable.”

What Does “Genetically Engineered Babies” Actually Mean?

The phrase “genetically engineered babies” can describe several very different technologies. Lumping them together creates confusion.

One category is preimplantation genetic testing, often called PGT. In this process, embryos are created through IVF, a small sample of cells may be tested, and the results may help clinicians and patients make decisions about embryo transfer. This is testing. It does not change an embryo’s DNA.

Another category is embryo selection. When more than one embryo is available, prospective parents and their fertility team may use testing information when deciding which embryo to transfer. The ethical and practical questions can be difficult, but the DNA is still not altered.

The third category is heritable genome editing. This would involve changing DNA in an egg, sperm, or embryo and then using that edited embryo to establish a pregnancy. Any genetic change could potentially be passed to the child’s descendants. This is the technology most people mean when they picture a truly genetically engineered baby.

What CRISPR Can Do and Why It Is Not Ready for Reproductive Use

CRISPR is a set of genome-editing tools that can be used to make targeted changes in DNA. It has become enormously important in laboratory science and has contributed to the development of treatments for some serious conditions.

There is an important difference between editing cells in a person who can consent to treatment and editing an embryo that could become a child. Somatic gene editing affects non-reproductive cells and is not meant to be inherited. Heritable editing affects the germline: eggs, sperm, embryos, or their precursor cells.

Heritable editing raises unresolved scientific questions. An edit may occur in some cells but not others, a problem called mosaicism. A change intended at one DNA location may have unintended effects elsewhere. More fundamentally, scientists cannot fully predict the lifelong consequences of changing a developing human genome or the effects on future generations.

The World Health Organization distinguishes between non-heritable genome editing, laboratory research involving germline cells, and heritable genome editing intended to establish a pregnancy. Its guidance emphasizes the need for strong governance, transparency, and oversight because the implications extend beyond one patient or one family.

Read the World Health Organization overview of human genome editing.

Are Genetically Edited Babies Legal in the United States?

There is currently no approved clinical pathway in the United States for creating a pregnancy with a genetically edited embryo. Heritable human genome editing is not an available fertility treatment that patients can simply purchase through a clinic.

Research rules differ by country and by institution. That does not mean the world is in a race to offer designer babies. Instead, it means governments, regulators, professional societies, scientists, disability advocates, ethicists, and the public are still debating what should be permitted, what should be prohibited, and what safeguards would be necessary.

The lack of a routine clinical pathway is not just about politics. It reflects unresolved questions about safety, reproducibility, long-term follow-up, consent from future generations, fairness, and the social consequences of making inherited changes to human DNA.

IVF Embryo Testing Is Not Embryo Editing

Preimplantation genetic testing has specific uses in fertility medicine. For families with a known inherited condition, testing may help identify embryos that are more or less likely to carry a particular genetic change. Other forms of testing examine chromosome number.

PGT can provide information. It does not guarantee a pregnancy, a healthy child, or a particular life outcome. It also has technical limits. A small number of cells are sampled, results must be interpreted carefully, and fertility specialists may recommend confirmatory testing during pregnancy depending on the situation.

It is also inaccurate to say that embryos with genetic conditions are simply never implanted. Decisions about embryo transfer are personal, medically complex, and ethically sensitive. Fertility clinicians provide information and recommendations, but patients’ choices and local laws vary.

Polygenic Embryo Screening: A Probability Tool, Not a Crystal Ball

Polygenic embryo screening, sometimes called PGT-P, tries to estimate the probability of certain complex conditions by combining information from many genetic variants. It is very different from testing for a single, well-understood inherited mutation.

Complex traits and conditions are influenced by many genes, environment, chance, family context, healthcare access, education, nutrition, and lived experience. A polygenic score does not predict a person’s intelligence, height, personality, athletic ability, or future health with certainty.

This is why claims about choosing an embryo for superior intelligence or elite athletic performance are far ahead of the evidence. Even when a score is statistically associated with a population-level outcome, its usefulness for choosing between a small number of embryos from the same family may be limited.

In late 2025, the American Society for Reproductive Medicine concluded that polygenic embryo screening lacks proven clinical utility and is not ready for clinical use. The organization also highlighted major scientific and ethical concerns.

See the ASRM statement on polygenic embryo screening.

Why “Designer Baby” Claims Mislead People

The term “designer baby” makes it sound as though parents can browse a menu of traits and order a child with guaranteed intelligence, beauty, health, height, strength, or personality. Current science cannot do that.

Most human traits are polygenic, meaning they involve many genetic variants. They are also shaped by environment and development. A person’s life cannot be reduced to a DNA score.

There is also a practical constraint that popular discussions often ignore: IVF typically produces a limited number of embryos. Even if a clinic provides genetic information, there may be little or no meaningful choice among embryos. That is very different from designing a person from scratch.

Science can identify some serious inherited risks. It cannot reliably write a future child’s abilities, values, relationships, mental health, or life outcome.

Why Safety Is Not the Only Concern

The ethical questions are not limited to whether CRISPR works accurately enough. They also concern who bears the risk, who benefits, and who is included in the decision.

An embryo cannot consent to a genetic change that could affect every cell in the body and potentially be passed to descendants. Families facing devastating inherited diseases may see a potential benefit in gene editing. Others may reasonably worry that the technology could create pressure to avoid, alter, or stigmatize people with disabilities.

Equity matters, too. Fertility treatment is already expensive and unevenly accessible. If powerful reproductive technologies became available only to wealthy people, they could widen existing social and health inequalities.

These concerns are why international guidance emphasizes public engagement, transparency, registries, ethical review, and protections against unsafe or unethical research. Read the WHO recommendations on governance and oversight of human genome editing.

The Eugenics Concern Must Be Taken Seriously

Eugenics refers to efforts to control reproduction in the name of improving humanity. Its history includes forced sterilization, discrimination, institutional abuse, and grave human-rights violations.

Modern reproductive medicine is not the same thing as historical eugenics. Helping a family understand the risk of a serious inherited disease is not equivalent to coercive state control over reproduction. Still, history is relevant because it reminds us to watch for pressure, discrimination, commercial exploitation, and assumptions that some lives are more valuable than others.

Ethical reproductive care should protect informed choice, disability rights, privacy, access to accurate information, and freedom from coercion. These principles matter whether the technology involves IVF, genetic testing, gene therapy, or a future technique that does not yet exist.

What Is Happening Now?

Genome-editing science is moving quickly, especially in research and in treatments that target non-heritable cells. Those developments may lead to better therapies for serious disease.

At the same time, creating children from genetically edited embryos remains a fundamentally different step. It is not a standard medical service. The risks and ethical questions are not solved by the fact that CRISPR exists.

For now, the most accurate view is neither “this will never happen” nor “designer babies are already here.” The tools are real. Some genetic testing in IVF is already clinical practice. Heritable embryo editing for reproduction remains outside accepted routine care and requires far more scientific understanding and public governance than we currently have.

Frequently Asked Questions

Do genetically engineered babies already exist?

There is no established, accepted clinical practice of using genetically edited embryos to create children. IVF embryo testing and embryo selection are different from heritable gene editing.

Can CRISPR eliminate inherited disease in embryos?

CRISPR can edit DNA in research settings, but using it to create a pregnancy from an edited human embryo is not an established or accepted medical treatment. Safety and ethical concerns remain substantial.

Can parents choose intelligence or athletic ability?

No. Complex traits are influenced by many genes and environmental factors. Current screening cannot reliably select or guarantee intelligence, athletic performance, personality, appearance, or a child’s future health.

Is polygenic embryo screening proven?

No. The American Society for Reproductive Medicine has concluded that polygenic embryo screening lacks proven clinical utility and is not ready for clinical use.

Does this mean IVF genetic testing is unethical?

No. Genetic testing in IVF can have legitimate uses, especially for families with a known inherited condition. It should be discussed with a qualified reproductive endocrinologist and genetic counselor who can explain the benefits, limits, and personal implications.

I am a licensed massage therapist, not a physician, genetic counselor, fertility specialist, or bioethicist. This article is general education, not medical, fertility, legal, or genetic advice. Please speak with qualified healthcare and genetic-counseling professionals about IVF, inherited conditions, reproductive decisions, or any significant health concern.

The Bottom Line

Genetically engineered babies are not a routine reality. What is real today is a fast-moving landscape of IVF, embryo testing, genetic research, and ethical debate.

The key is to use precise language. Testing is not editing. Probability is not destiny. And scientific possibility is not the same as an ethically acceptable, safe, or clinically available treatment. The future of human genetics should be shaped by evidence, humility, public accountability, and respect for human dignity.

Riktr PRO Massage: Injury Recovery

Standard Mon - Fri: $150/hr

Student Weekday Special: $80/hr w/ ID - Must Mention Promo
(Save $45 - Mon-Fri)

Weekends & Holidays: $175/hr

📍 827 State St, Suite 20, SB 93101

View on Google Maps

First-time clients: A $25 deposit is required to hold your appointment time and is applied to your session.

Book Online Now

Or Text: 805-637-7482

 

 

Therapeutic Deep Tissue, Swedish, and Sports Massage Therapy in Santa Barbara, Goleta, CA
 

 

*Disclaimer: 

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. This is not medical advice, and you should always consult your primary care doctor or a qualified healthcare provider regarding any specific health problem or disease. Nearly 2 decades of therapeutic bodywork experience provide a clinical perspective, but individual results may vary, and specific outcomes are not guaranteed. Clinical bodywork involves intense physical manipulation; it is the reader’s responsibility to ensure they are healthy enough for such activity and to disclose all medical conditions to their provider. The decision to act on any information provided is the sole responsibility of the reader. All trademarks and brand names referenced are the property of their respective owners.

Leave a Reply

Your email address will not be published. Required fields are marked *